Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UMP Healthcare HoldingsHKSE:00722 56 EBITDA Margin % is 20.64% as of Dec. 2025, which is 3% below its 10-year median of 21.35. GuruFocus rates HKSE:00722 with a GF Score™ of 56/100 and a GF Value™ of HK$0.49 (Fairly Valued). The stock has 6 warning signs investors should review. Among 665 Healthcare Providers & Services companies, UMP Healthcare Holdings ranks better than 76.69% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
UMP Healthcare Holdings EBITDA Margin % Related Terms
UMP Healthcare Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00722 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, UMP Healthcare Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UMP Healthcare Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, UMP Healthcare Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where UMP Healthcare Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UMP Healthcare Holdings (HKSE:00722) has a EBITDA Margin % of 20.64% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on UMP Healthcare Holdings and its competitors. This is near median its historical median of 21.35. Over the past decade, UMP Healthcare Holdings' EBITDA Margin % has ranged from 10.04 to 27.89. According to the industry distribution chart, UMP Healthcare Holdings ranks #155 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 23.3%.
Is UMP Healthcare Holdings' EBITDA Margin % too high?
UMP Healthcare Holdings' current EBITDA Margin % of 20.64% is near median its 10-year median of 21.35. Over the past 10 years, this metric has ranged from a low of 10.04 to a high of 27.89. The Healthcare Providers & Services industry median EBITDA Margin % is 10.23. UMP Healthcare Holdings' value of 20.64% is 101.8% above this industry median. Based on the distribution chart, UMP Healthcare Holdings ranks #155 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, UMP Healthcare Holdings has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UMP Healthcare Holdings' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, UMP Healthcare Holdings ranks #155 out of 665 companies for EBITDA Margin %. This places UMP Healthcare Holdings in the top 23% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.23. UMP Healthcare Holdings' value of 20.64% is 101.8% above this benchmark. Historically, UMP Healthcare Holdings' own EBITDA Margin % has ranged from 10.04 to 27.89 over the past decade. While the company's 10-year median is 21.35 vs. the industry median of 10.23, UMP Healthcare Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.23, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UMP Healthcare Holdings's current EBITDA Margin % of 20.64% is 101.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on UMP Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UMP Healthcare Holdings's current EBITDA Margin % is 20.64%, which is near median its own 10-year median of 21.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UMP Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, UMP Healthcare Holdings (HKSE:00722) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.49, compared to a current price of HK$0.45 — trading 9.2% below its estimated fair value. The current EBITDA Margin % is 20.64%, which is near median its 10-year median of 21.35 and 101.8% above the Healthcare Providers & Services industry median of 10.23. UMP Healthcare Holdings' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For UMP Healthcare Holdings (HKSE:00722), the current EBITDA Margin % is 20.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UMP Healthcare Holdings (HKSE:00722) Overvalued in 2026?
Based on GuruFocus' analysis, UMP Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.45 is trading 9.2% below its estimated GF Value™ of HK$0.49.
GuruFocus considers UMP Healthcare Holdings to be Fairly Valued.
Key valuation signals for HKSE:00722:
EBITDA Margin %: 20.64% (near median its 10-year median of 21.35)
GF Value™: HK$0.49 vs. price of HK$0.45 (9.2% below fair value)
Industry Position: 101.8% above the Healthcare Providers & Services median (#155 of 665)
No single metric tells the full story. See the HKSE:00722 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UMP Healthcare Holdings Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the provision of healthcare services that include corporate healthcare solution services, medical and dental services, medical imaging and laboratory services, other auxiliary medical services, and healthcare management services. The reportable operating business segments are Hong Kong & Macau Clinical Healthcare Services, which derives maximum revenue; Hong Kong & Macau Corporate Healthcare Solution Services; and Mainland China Clinical Healthcare Services. Its geographical segments include Hong Kong, Mainland China, and Macau, of which the majority of its revenue comes from Hong Kong.
56GF Score
Get the complete analysis for HKSE:00722
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00722 has been successfully added to your 
